1.
Wang S, Lau LS, Lee AS. CORPORATE ENVIRONMENTAL DISCLOSURE, CORPORATE GOVERNANCE, AND COST OF DEBT IN CHINA’S PHARMACEUTICAL INDUSTRY. IJEMP [Internet]. 2025 Aug. 11 [cited 2026 Nov. 15];8(31). Available from: https://www.gaexcellence.com/index.php/ijemp/article/view/5666